Filing Flows

Filing Flows › Bioventus (BVS) › Next earnings date

Bioventus (BVS) earnings: beat the estimate

Bioventus (BVS) reported on Nov 2, 2026 and beat the EPS estimate: $0.17 against $0.16 (+6.2%). Revenue was $142M for Q3 2026, +3% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+6.2% vs estimate
Beat rate100%

The last report

Bioventus reported revenue of $142M for the third quarter 2026 (+3% Y/Y), net earnings $6.0M. How it makes money → · Every quarter →

Bioventus: EPS against the estimate, last 5 reportsBioventus: EPS against the estimate, last 5 reportsEstimateReported$0.12$0.15Nov 25$0.22$0.24Mar 26$0.07$0.15May 26$0.22$0.22Aug 26$0.16$0.17Nov 26
Latest (Nov 26): Estimate $0.16, Reported $0.17.

Bioventus' latest quarter

Bioventus, Q3 2026: revenue $142M (+3% year over year), operating margin 6.8%, net earnings $6.0M, operating cash flow $20.7M. The chart follows the revenue to costs, profit and cash.

Questions

Did Bioventus beat earnings?

Bioventus (BVS) reported on Nov 2, 2026 and beat the EPS estimate: $0.17 against $0.16 (+6.2%).

When does BVS report earnings?

The next date is not set yet.

Does Bioventus usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.